MSCE, Children's Hospital of Philadelphia, Division of Emergency Medicine, Main AS01, 34th Street and Civic Center Boulevard, Philadelphia, PA 19104-4399, USA.
Pediatrics. 2010 Feb;125(2):342-9. doi: 10.1542/peds.2009-2092. Epub 2010 Jan 25.
Viral bronchiolitis is a leading cause of acute illness and hospitalization of young children. Research into the variation in treatment and outcomes for bronchiolitis across different settings has led to evidence-based clinical practice guidelines. Ongoing investigation continues to expand this body of evidence. Authors of recent surveillance studies have defined the presence of coinfections with multiple viruses in some cases of bronchiolitis. Underlying comorbidities and young age remain the most important predictors for severe bronchiolitis. Pulse oximetry plays an important role in driving use of health care resources. Evidence-based reviews have suggested a limited role for diagnostic laboratory or radiographic tests in typical cases of bronchiolitis. Several large, recent trials have revealed a lack of efficacy for routine use of either bronchodilators or corticosteroids for treatment of bronchiolitis. Preliminary evidence suggests a potential future role for a combination of these therapies and other novel treatments such as nebulized hypertonic saline.
病毒性细支气管炎是导致婴幼儿急性疾病和住院的主要原因。对不同环境中细支气管炎的治疗和结果变化的研究,促成了基于证据的临床实践指南。持续的研究不断扩展这方面的证据。最近的监测研究的作者在某些细支气管炎病例中定义了多种病毒的合并感染。潜在的合并症和年龄较小仍然是严重细支气管炎最重要的预测因素。脉搏血氧饱和度在推动医疗资源的使用方面发挥着重要作用。基于证据的综述表明,在典型的细支气管炎病例中,诊断性实验室或影像学检查的作用有限。几项大型的最新试验表明,常规使用支气管扩张剂或皮质类固醇治疗细支气管炎的效果不佳。初步证据表明,这些疗法的联合应用以及其他新型疗法(如雾化高渗盐水)可能具有潜在的未来作用。